Skip to Main Content

2,520

Views

7

CrossRef citations to date

0

Altmetric

Original Article

Effectiveness and safety of initiating adalimumab plus ≥12 mg/week methotrexate with adjustable dosing in biologic-naïve patients with early rheumatoid arthritis: HAWK study postmarketing surveillance in Japan

Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan; Correspondence[email protected]
View further author information

,

Tsuneyo MimoriDepartment of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; View further author information

,

Hisashi YamanakaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; View further author information

,

Ryo NakajimaAbbVie GK, Tokyo, Japan; View further author information

,

Kazuo MoritaAbbVie GK, Tokyo, Japan; View further author information

,

Junko KimuraAbbVie GK, Tokyo, Japan; View further author information

&

Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, JapanView further author information